POINT - Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain
NCT ID: NCT05828121
Last Updated: 2023-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2022-10-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Substance Use and Lifestyle-related Health Problems in Ageing Patients in OMT Treatment
NCT05182918
Return to Work - Will Brief Intervention Reduce Opioid-induced Back Pain?
NCT05437861
Long-Term Opioid Therapy in Chronic Non-Cancer Pain: Risks and Benefits
NCT06063902
Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
NCT01717963
Predictive Markers of the Effects of Opioid Therapy
NCT02308306
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Several factors-the escalating use of opioids to chronic pain patients, the increasing use of strong opioids in particular, and the increasing number of overdoses caused by prescription opioids-point to the start of an opioid epidemic in Norway.
Objectives The overall goal of the POINT project is to provide knowledge to optimize treatment of patients with chronic pain in order to avoid unnecessary escalation of opioid treatment, improve their quality of life and reduce the burden of disease.
In the long run our objective is to prevent the unwanted consequences of opioid treatment and improve patients' quality of life.
Ultimately, through this project the investigators hope to prevent an opioid epidemic in Norway.
To achieve the main goal, the investigators will focus on pain patients and their doctors, as increasing opioid use may occur through the patient-doctor interaction.
Methods
The project will develop and test a non-drug interventions that consist of an interdisciplinary group treatment .
Financing The Research Council of Norway
Cooperation St. Olavs Hospital
Stavanger Hospital Trust
City of Stavanger
National Institute of Public Health (FHI)
Alcohol and Drug Research Western Norway (KoRFor)
Foreningen for kroniske smertepasienter (FKS) Norwegian Forum of Disabled Peoples' Organizations (SAFO)
Cooperation with other projects Injury Prevention and Outcomes following Trauma
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SEQUENTIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Point1
Receiving treatment
POINT1
Receiving treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
POINT1
Receiving treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Registered in Stavanger municipality
* Consent to participation.
* Age 18 - 67 years
* Pain duration \<10 years
Exclusion Criteria
18 Years
67 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Research Council of Norway
OTHER
Helse Stavanger HF
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kine Gjesdal
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stavanger municipality
Stavanger, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
kine gjesdal, phd
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
POINTstavanger
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.